BI-69A11 Inhibitor

BI-69A11 is a dual AKT and NFkB pathway inhibitor. It enhances the susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.

1 Pa I Sarka S e al BI-69A1 enhance susceptibilit o colo cance cell t mda-7/IL-24-induce growt inhibitio b targetin Akt B Cancer 201 Ju 8 11(1):101-11.
2 Pa I Parid S e al Blockad o autophag enhance proapoptoti potentia o BI-69A11 nove Ak inhibitor i colo carcinoma Eu Pharmacol 201 Oc 15 65:217-27.
3 Fen Y La E e al Inhibitio o melanom developmen i th Nras((Q61K) :Ink4a(-/- mous mode b th smal molecul BI-69A11 Pigmen Cel Melanom Res 201 Jan 6(1):136-42 href="javascript:void(0) rel="nofollow >
4 Pa I De KK Chaurasi M Parid S Da S Rajes Y Sharm K Chowdhur T Manda M Cooperativ effec o BI-69A1 an celecoxi enhance radiosensitizatio b modulatin DN damag repai i colo carcinoma uMou Biol 201 May 7(5):6389-402 doi 10.1007/s13277-015-4399-6 Epu 201 De 2 PubMe PMID 26631035.

Small volumes of BI-69A11, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5774884 is an inhibitor targeting BI-69A11.